Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients

Molecular Vision

Volumn 15, Issue , 2009, Pages 1270-1276

  Saglar, E ^a   Yucel, D ^a   Bozkurt, B ^b   Ozgul, R K ^a   Irkec, M ^a   Ogus, Ay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ARGININE; PROLINE; PROTEIN P21; PROTEIN P53; SERINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OPEN ANGLE GLAUCOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE SIZE; TONOMETRY; TURKEY (REPUBLIC); VISUAL FIELD;

AGED; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENES, P53; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 67650651977     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-93.
2. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6:641-7.
3. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275:668-70.
4. Budde WM. Heredity in primary open-angle glaucoma. Curr Opin Ophthalmol 2000; 11:101-6.
5. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295:1077-9.
6. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J, Ritch R, Heon E, Crick RP, Child A, Sarfarazi M. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005; 14:725-33.
7. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for primary open angle glaucoma. Clin Biochem 2006; 39:249-58.
8. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14:55-61.
9. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52:244-8.
10. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350:1069-71.
11. Saunders AM, Trowers MK, Shimkets RA, Blakemore S, Crowther DJ, Mansfield TA, Wallace DM, Strittmatter WJ, Roses AD, Shimkets RA. The role of Apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochim Biophys Acta 2000; 1502:85-94.
12. Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003; 84:1215-36.
13. Amaratunga A, Abraham CR, Edwards RB, Sandell JH, Schreiber BM, Fine RE. Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J Biol Chem 1996; 271:5628-32.
14. Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, Dickinson JL, McCartney PJ, Coote MA, Healey DL, Mackey DA. The apolipoprotein ε4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 2002; 8:389-93.
15. Bayer AU, Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye 2002; 16:209-12.
16. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002; 133:135-7.
17. Junemann A, Bleich S, Reulbach U, Henkel K, Wakili N, Beck G, Rautenstrauss B, Mardin C, Naumann GO, Reis A, Kornhuber J. Prospective case control study on genetic assocation of apolipoprotein epsilon2 with intraocular pressure. Br J Ophthalmol 2004; 88:581-2.
18. Yuan HP, Xiao Z, Yang BB. A study on the association of apolipoprotein E genotypes with primary open-angle glaucoma and primary angle-closure glaucoma in northeast of China Chinese. [Article in Chinese]. Zhonghua Yan Ke Za Zhi 2007; 43:416-20.
19. Mabuchi F, Tang S, Ando D, Yamakita M, Wang J, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol Vis 2005; 11:609-12.
20. Lam CY, Fan BJ, Wang DY, Tam PO, Yung Tham CC, Leung DY, Ping Fan DS, Chiu Lam DS, Pang CP. Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population. J Glaucoma 2006; 15:218-22.
21. Fan BJ, Wang DY, Fan DS, Tam PO, Lam DS, Tham CC, Lam CY, Lau TC, Pang CP. SNPs and interaction analyses of myocilin, optineurin and apolipoprotein E in primary open angle glaucoma patients. Mol Vis 2005; 11:625-31.
22. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. The role of apolipoprotein E gene polymorphisms in primary open angle glaucoma. Arch Ophthalmol 2004; 122:258-61.
23. Lake S, Liverani E, Desai M, Casson R, James B, Clark A, Salmon JF. Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms. Br J Ophthalmol 2004; 88:491-3.
24. Zetterberg M, Tasa G, Palmér MS, Juronen E, Teesalu P, Blennow K, Zetterberg H. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma. Am J Ophthalmol 2007; 143:1059-60.
25. Jia LY, Tam PO, Chiang SW, Ding N, Chen LJ, Yam GH, Pang CP, Wang NL. Multiple gene polymorphisms analysis revealed a different profile of genetic polymorphisms of primary open-angle glaucoma in northern Chinese. Mol Vis 2009; 15:89-98.
26. Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol 1999; 43:S151-61.
27. Osborne NN, Wood JP, Chidlow G, Bae JH, Melena J, Nash MS. Ganglion cell death in glaucoma: what do we really know? Br J Ophthalmol 1999; 83:980-6.
28. Read AP, Strachan T. "Chapter 18: Cancer Genetics". Human molecular genetics 2. New York: Wiley; 1999.
29. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med 2003; 54:73-87.
30. Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53-dependent cell death signaling in neurons. Neurochem Res 2003; 28:15-27.
31. Lin HJ, Chen WC, Tsai FJ, Tsai SW. Distributions of p53 codon 72 polymorphism in primary open angle glaucoma. Br J Ophthalmol 2002; 86:767-70.
32. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. Primary open angle glaucoma is associated with a specific p53 gene haplotype. J Med Genet 2004; 41:296-8.
33. Shih CM, Lin PT, Wang HC, Huang WC, Wang YC. Lack of evidence of association of p21WAFI/CIPI polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res 2000; 91:9-15.
34. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D, Mushinski JF. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21. Oncogene 1994; 9:3017-20.
35. Terry LA, Boyd J, Alcorta D, Lyon T, Solomon G, Hannon G, Berchuck A, Beach D, Barrett JC. Mutational analysis of the p21/WAF1/CIP1/SID1 coding region in human tumour cell lines. Mol Carcinog 1996; 16:221-8.
36. Tsai FJ, Lin HJ, Chen WC, Tsai CH, Tsai SW. A codon 31ser-arg polymorphism of the WAF-1/CIP-1/p21/tumour suppressor gene in Chinese primary open-angle glaucoma. Acta Ophthalmol Scand 2004; 82:76-80.
37. Ressiniotis T, Griffiths PG, Keers SM, Chinnery PF, Birch M. A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians. BMC Ophthalmol 2005; 5:5.
38. Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 2002; 70:1575-81.
39. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. Apolipoprotein E promoter polymorphisms do not have a major influence on the risk of developing primary open angle glaucoma. Mol Vis 2004; 10:805-7.
40. Dumont P. I-Ju Leu J, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33:357-65.
41. McKinnon SJ. Glaucoma, apoptosis, and neuroprotection. Curr Opin Ophthalmol 1997; 8:28-37.
42. Acharya M, Mitra S, Mukhopadhyay A, Khan M, Roychoudhury S, Ray K. Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients. Mol Vis 2002; 8:367-71.
43. Dimasi DP, Hewitt AW, Green CM, Mackey DA, Craig JE. Lack of association of p53 polymorphisms and haplotypes in high and normal tension open angle glaucoma. J Med Genet 2005; 42:e55.
44. Birgander R, Sjalander A, Saha N. The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. Hum Hered 1996; 46:148-54.